 | Up a level |
Rottenburger, Christof; Hentschel, Michael; Fürstner, Markus; McDougall, Lisa; Kottoros, Danijela; Kaul, Felix; Mansi, Rosalba; Fani, Melpomeni; Vija, A Hans; Schibli, Roger; Geistlich, Susanne; Behe, Martin; Christ, Emanuel R; Wild, Damian (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI research, 14(37) Springer 10.1186/s13550-024-01101-w
Bengs, Susan; Warnock, Geoffrey I; Portmann, Angela; Mikail, Nidaa; Rossi, Alexia; Ahmed, Hazem; Etter, Dominik; Treyer, Valerie; Gisler, Livio; Pfister, Stefanie K; Jie, Caitlin V M L; Meisel, Alexander; Keller, Claudia; Liang, Steven H; Schibli, Roger; Mu, Linjing; Buechel, Ronny R; Kaufmann, Philipp A; Ametamey, Simon M; Gebhard, Catherine; ... (2023). Rest/stress myocardial perfusion imaging by positron emission tomography with 18F-Flurpiridaz: A feasibility study in mice. Journal of nuclear cardiology, 30(1), pp. 62-73. Springer 10.1007/s12350-022-02968-9
Rottenburger, Christof; Nicolas, Guillaume P; McDougall, Lisa; Kaul, Felix; Cachovan, Michal; Vija, A Hans; Schibli, Roger; Geistlich, Susanne; Schumann, Anne; Rau, Tilman; Glatz, Kathrin; Behe, Martin; Christ, Emanuel R; Wild, Damian (2020). Cholecystokinin-2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma - Results of the Lumed Phase 0a Study. Journal of nuclear medicine, 61(4), pp. 520-526. Society of Nuclear Medicine 10.2967/jnumed.119.233031
Müller, Cristina; De Prado Leal, Maria; Dominietto, Marco D; Umbricht, Christoph A; Safai, Sairos; Perrin, Rosalind L; Egloff, Martina; Bernhardt, Peter; van der Meulen, Nicholas P; Weber, Damien C.; Schibli, Roger; Lomax, Antony J (2019). Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute. Pharmaceutics, 11(9) MDPI 10.3390/pharmaceutics11090450
Sah, Bert-Ram; Sommerauer, Michael; Mu, Linjing; Gonzalez, Gloria Pla; Geistlich, Susanne; Treyer, Valerie; Schibli, Roger; Buck, Alfred; Warnock, Geoffrey; Ametamey, Simon M (2019). Radiation dosimetry of [F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humans. EJNMMI research, 9(1), p. 56. Springer 10.1186/s13550-019-0522-9
Baum, Richard P.; Singh, Aviral; Benešová, Martina; Vermeulen, Christiaan; Gnesin, Silvano; Köster, Ulli; Johnston, Karl; Müller, Dirk; Senftleben, Stefan; Kulkarni, Harshad R.; Türler, Andreas; Schibli, Roger; Prior, John O.; van der Meulen, Nicholas P.; Müller, Cristina (2017). Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152 Tb-DOTATOC. Dalton transactions, 46(42), pp. 14638-14646. Royal Society of Chemistry 10.1039/C7DT01936J
Domnanich, Katharina Anna; Eichler, Robert; Müller, Cristina; Jordi, Sara Laura; Yakusheva, Vera; Braccini, Saverio; Behe, Martin; Schibli, Roger; Türler, Andreas; van der Meulen, Nicholas P. (2017). Production and separation of 43Sc for radiopharmaceutical purposes. EJNMMI Radiopharmacy and Chemistry, 2(1) Springer 10.1186/s41181-017-0033-9
Domnanich, Katharina Anna; Müller, Cristina; Benešová, Martina; Dressler, Rugard; Haller, Stephanie; Köster, Ulli; Ponsard, Bernard; Schibli, Roger; Türler, Andreas; van der Meulen, Nicholas P. (2017). 47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes. EJNMMI Radiopharmacy and Chemistry, 2(1) Springer 10.1186/s41181-017-0024-x
Singh, Aviral; van der Meulen, Nicholas P.; Müller, Cristina; Klette, Ingo; Kulkarni, Harshad R.; Türler, Andreas; Schibli, Roger; Baum, Richard P. (2017). First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44 Sc-DOTATOC: A Proof-of-Concept Study. Cancer biotherapy and radiopharmaceuticals, 32(4), pp. 124-132. Mary Ann Liebert 10.1089/cbr.2016.2173
Mu, Linjing; Müller Herde, Adrienne; Rüefli, Pascal; Sladojevich, Filippo; Sephton, Selena Milicevic; Krämer, Stefanie D.; Thompson, Andrew James; Schibli, Roger; Ametamey, Simon M.; Lochner, Martin (2016). Synthesis and Pharmacological Evaluation of [11C]granisetron and [18F]fluoropalonosetron as PET Probes for 5-HT3 Receptor Imaging. ACS chemical neuroscience, 7(11), pp. 1552-1564. American Chemical Society 10.1021/acschemneuro.6b00192
Domnanich, Katharina Anna; Müller, Cristina; Farkas, Renata; Schmid, Raffaella M.; Ponsard, Bernard; Schibli, Roger; Türler, Andreas; van der Meulen, Nicholas P. (2016). 44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. EJNMMI Radiopharmacy and Chemistry, 1(1), p. 8. Springer 10.1186/s41181-016-0013-5
Bunka, Maruta; Müller, Cristina; Vermeulen, Christiaan; Haller, Stephanie; Türler, Andreas; Schibli, Roger; van der Meulen, Nicholas P. (2016). Imaging quality of 44Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET. Applied radiation and isotopes, 110, pp. 129-133. Elsevier 10.1016/j.apradiso.2016.01.006
Müller, Cristina; Vermeulen, Christiaan; Köster, Ulli; Johnston, Karl; Türler, Andreas; Schibli, Roger; van der Meulen, Nicholas P. (2016). Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics. EJNMMI Radiopharmacy and Chemistry, 1(1), p. 5. Springer 10.1186/s41181-016-0008-2
van der Meulen, Nicholas P.; Bunka, Maruta; Domnanich, Katharina A.; Müller, Cristina; Haller, Stephanie; Vermeulen, Christiaan; Türler, Andreas; Schibli, Roger (2015). Cyclotron production of 44Sc: From bench to bedside. Nuclear medicine and biology, 42(9), pp. 745-751. Elsevier 10.1016/j.nucmedbio.2015.05.005
Grünberg, Jürgen; Lindenblatt, Dennis; Dorrer, Holger; Cohrs, Susan; Zhernosekov, Konstantin; Köster, Ulli; Türler, Andreas; Fischer, Eliane; Schibli, Roger (2014). Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. European journal of nuclear medicine and molecular imaging, 41(10), pp. 1907-1915. Springer 10.1007/s00259-014-2798-3
Müller, Cristina; Reber, Josefine; Haller, Stephanie; Dorrer, Holger; Bernhardt, Peter; Zhernosekov, Konstantin; Türler, Andreas; Schibli, Roger (2014). Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate. European journal of nuclear medicine and molecular imaging, 41(3), pp. 476-485. Springer 10.1007/s00259-013-2563-z
Müller, Cristina; Fischer, Eliane; Behe, Martin; Köster, Ulli; Dorrer, Holger Johann; Reber, Josefine; Haller, Stephanie; Cohrs, Susan; Blanc, Alain; Grünberg, Jürgen; Bunka, Maruta; Zhernosekov, Konstantin; van der Meulen, Nicholas; Johnston, Karl; Türler, Andreas; Schibli, Roger (2014). Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice. Nuclear medicine and biology, 41 Suppl, e58-65. Elsevier 10.1016/j.nucmedbio.2013.11.002
Müller, Cristina; Bunka, Maruta; Haller, Stephanie; Köster, Ulli; van der Meulen, Nicholas; Türler, Andreas; Schibli, Roger (2014). Preclinical application of 47Sc-folate – A pilot study in tumor-bearing mice. Nuclear medicine and biology, 41(7), p. 638. Elsevier 10.1016/j.nucmedbio.2014.05.026
Müller, Cristina; Reber, Josefine; Haller, Stephanie; Dorrer, Holger; Köster, Ulli; Johnston, Karl; Zhernosekov, Konstantin; Türler, Andreas; Schibli, Roger (2014). Folate Receptor Targeted Alpha-Therapy Using Terbium-149. Pharmaceuticals, 7(3), pp. 353-365. MDPI 10.3390/ph7030353
Müller, Cristina; Bunka, Maruta; Reber, Josefina; Fischer, Cindy; Zhernosekov, Konstantin; Türler, Andreas; Schibli, Roger (2013). Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate. Journal of nuclear medicine, 54(12), pp. 2168-2174. Society of Nuclear Medicine 10.2967/Jnumed.113.123810
Müller, Christina; Zhernosekov, Konstantin; Köster, Ulli; Johnston, Karl; Dorrer, Holger; Hohn, Alexander; van der Walt, Nico T.; Türler, Andreas; Schibli, Roger (2012). A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative. Journal of nuclear medicine, 53(12), pp. 1951-1959. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.112.107540
Lehenberger, Silvia; Barkhausen, Christoph; Cohrs, Susan; Fischer, Eliane; Grünberg, Jürgen; Hohn, Alexander; Köster, Ulli; Schibli, Roger; Türler, Andreas; Zhernosekov, Konstantin (2011). The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy. Nuclear medicine and biology, 38(6), pp. 917-924. Oxford: Elsevier 10.1016/j.nucmedbio.2011.02.007
Mumprecht, Viviane; Honer, Michael; Vigl, Benjamin; Proulx, Steven T; Trachsel, Eveline; Kaspar, Manuela; Banziger-Tobler, Nadja E; Schibli, Roger; Neri, Dario; Detmar, Michael (2010). In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. Cancer research, 70(21), pp. 8842-8851. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-10-0896
Dorrer, Holger Johann; Köster, Ulli; Müller, Cristina; Johnston, Karl; Schibli, Roger; Türler, Andreas; Zhernosekov, Konstantin (2011). Herstellung von Terbium-Radioisotopen für diagnostische und therapeutische Anwendungen in der Nuklearmedizin. In: 19. Jahrestagung der Arbeitsgemeinschaft Radiochemie/Radiopharmazie. Ochsenfurt bei Würzurg, Germany. 15-17 September 2011.
